NCT01673880View on ClinicalTrials.gov

Open-Label Study of Bioavailability of E2006 Tablet Versus Capsule Formulations

PHASE1CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

August 31, 2012

Primary Completion Date

October 31, 2012

Study Completion Date

December 31, 2012

Conditions
Insomnia
Interventions
DRUG

E2006

2.5 mg, 10 mg, and 25 mg E2006 tablets

Trial Locations (1)

78704

PPD Development, LLC, Austin

All Listed Sponsors
lead

Eisai Inc.

INDUSTRY

NCT01673880 - Open-Label Study of Bioavailability of E2006 Tablet Versus Capsule Formulations | Biotech Hunter | Biotech Hunter